This inventor holds 9 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Children's Medical Center Corporation, Dana-Farber-Cancer Institute Inc.. Active years: 2012-2026.
Company Filing History:
9 out of 1,072 
2 out of 1,264 
Years Active: 2012-2026
Title: The Innovations of Richard Gregory
Introduction
Richard Gregory is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of hemoglobinopathies. With a total of 9 patents to his name, Gregory's work has the potential to impact the lives of many individuals suffering from blood disorders.
Latest Patents
Among his latest patents, Gregory has developed compositions and methods for treating hemoglobinopathies. These embodiments provide specially designed synthetic BCL11A-targeting microRNAs for RNA polymerase II expression. The methods aim to treat conditions such as sickle cell disease or thalassemia by increasing the expression levels of fetal hemoglobin.
Career Highlights
Throughout his career, Richard Gregory has worked with esteemed organizations, including Children's Medical Center Corporation and Dana-Farber Cancer Institute Inc. His innovative approaches and dedication to research have positioned him as a key figure in the medical community.
Collaborations
Some of his notable coworkers include Michael Milsom and David A. Williams. Their collaborative efforts have contributed to the advancement of research in the field of hemoglobinopathies.
Conclusion
Richard Gregory's work exemplifies the spirit of innovation in medical research. His contributions to treating hemoglobinopathies through targeted therapies highlight the importance of scientific advancements in improving patient outcomes.